New solutions for multiple myeloma patients with 14;16 and 14;20 translocations with Dr. Frank Zhan, MD, PhD and Dr. Guido Tricot, MD, PhD, University of Iowa
The 14;16 and 14;20 myeloma translocations are rare - in about 6% of all patients. These patients can respond to therapy just like normal risk patients,
Posted by
HealthTree